Author: Naseer Basma

I am a PhD Cancer Researcher at the Cancer Research UK (CRUK) Manchester Institute working on multiple projects to better understand the genetic and epigenetic events that drive various leukaemia types. My primary project investigating a leukaemia called myelofibrosis represents the convergence of the interests of various collaborators including Imago Biosciences Ltd, a clinical-stage therapeutics company who are funding the project, senior haematologists within the Christie Hospital and scientists in the CRUK institute. I have previously obtained a BSc(Hons) in Pharmacology from the University of Manchester and an MRes in Biomedical Sciences and Translational Medicine from the University of Liverpool. Through these degrees and my current work, I have learned about the significance of the various intersections between academia, industry and the clinic in delivering more effective cancer therapies and ultimately improving patient care. With that said, I am fascinated by the application of scientific discovery in the innovation space. This drove me to seek a position within the Innovation Forum, where I have strengthened my understanding of innovation and entrepreneurship, and have become familiarized with currently adopted strategies to accelerate the speed of technology adoption in the healthcare sector. I have also developed various connections and relationships with like-minded individuals within the scientific community, innovators within the life sciences space, and senior industry leaders.

Widening Sustainability Horizons Through Biotech Innovation

Sustainability has become a topic of increasing interest in today’s world. Day-to-day human activities have always involved using resources from nature, but it is commonplace that the resources used are finite and/or non-biodegradable. Indeed, the planet is still a lot larger than the scale of human activities have reached today, but with the persistent and uncontrolled usage of such high-risk resources over the centuries, their harmful effects have become even more prominent. 

A well-known environmental crisis you most likely have heard of is global warming. Fossil fuel burning has long been increasing the levels of carbon dioxide – a greenhouse gas that traps heat – in the atmosphere [1], which has gradually raised its temperature. Warmer atmospheric temperatures have subsequently warmed the oceans, melted glaciers and ice caps, and worsened weather conditions, leading to rising sea levels, intensified heat waves and droughts, and an increased frequency of destructive storms [2]. This has culminated in the destruction of animal habitats, bleaching of coral reefs, and irreparable damage to people’s livelihoods and communities.

Other human activities affect the global population just as significantly. For example, the food production industry releases greenhouse gases like methane which account for 35% of global emissions, with animal agriculture representing 57% of these emissions [3]. Cattle farming has been found to be responsible for the destruction of 80% of Amazon forests and 3.4% of global greenhouse gas emissions. The use of non-biodegradable plastics is also popularly known to fill oceans and kill wildlife through the ingestion of microplastics that wound them, and impair their feeding capacity, breeding capacity and ability to avoid predators. Microplastics are formed from the breakdown of these non-biodegradable plastics, and an average of 68% of 337 fishes sampled from the Mediterranean Sea were found to carry a notably large amount of microplastics [4]. 

The frequency and magnitude of the effects of global warming are expected to increase without immediate collective intervention. The United Nations, therefore, launched the Sustainable Development Goals (SDG) agenda in 2015 to address ongoing worldwide issues including the aforementioned sustainability problems. As a result, many big companies today across a wide variety of sectors are responding to the government’s call to achieve these goals. For example, The Coca-Cola Company has reported their investment in the development of 100% plant-based biodegradable plastic bottles [5].

The concerns for sustainability bring in demands for technological innovation in a wide variety of areas.  Innovation in biotechnology, in particular, is bound to play a big role in this sustainability movement. 

 How can biotechnology help sustainability?

Biotechnology is a powerful scientific field that can help the world become more sustainable by harnessing nature’s intelligence perfected in millions of years of evolution [6]. According to the Merriam-Webster dictionary, biotechnology is defined as ‘the manipulation (as through genetic engineering) of living organisms or their components to produce useful, usually commercial products (such as pest resistant crops, new bacterial strains, or novel pharmaceuticals)’ [7].  Biotechnology tackles the sustainability issue in two main ways. First, by using biotechnology, biologically derived products are produced through alternative, more sustainable processes compared to traditional ones. For example, the production of flavourings through biotechnology is a more sustainable process compared to the traditional extraction method from large quantities of plants. Additionally, biotechnology can offer solutions to environmental damage through clean technology. One example is represented by genetically manipulated microorganisms that can clean up oil spills [8].

Biotechnology is already making an impact in several sectors such as agriculture, energy, the food industry, and materials. For example, in agriculture, the cultivation of genetically modified plants leads to higher crop yields, increased resistance to pests, and smaller cropland surfaces that are used. Additionally, crops can be enriched with beneficial compounds. For example, the widely known Golden Rice project, recently approved in the Philippines, aims to combat vitamin A deficiency in low-income countries through the genetic modification of rice plants to synthesise carotenes [9]. Biotechnology also positively impacts the energy sector. For example, the UK start-up company Vivergo Fuels produces biofuels from the excessive starch component of wheat crops, embracing the concept of circular economy [10]. Similarly, biological fibre waste can be recycled into sugars which are further used in the food industry [11].

A significant contribution of biotechnology in the food sector is represented by cultured and plant-based meats, aiming to meet the increased demand of a growing global population whilst eliminating slaughter, reducing the use of antibiotics, and supporting sustainability through utilising less energy, water and land and reducing CO2 emissions [12]. Companies such as Quest Meat in the UK work extensively researching optimum ingredients and bioprocessing tools for the growing sector of cultured meat [13]. Connected to the food industry is the problem of single-use plastic packaging, which can be successfully tackled using biodegradable (and even edible) engineered protein-based packaging. This is the case of Xompla, a successful start-up company in the UK that has already reached the market through a partnership with meal kit retailer Gousto, saving around 17 tonnes of plastic packaging per year [14, 15].

Biotechnology also has an impact on our everyday activities. For example, enzymes present in new-generation detergents can save energy through their action at lower temperatures, compared to surfactants-only based formulas [6]. The fashion industry also benefits from biotechnology, either through the use of more sustainable and less hazardous dyes [6,16] or through the use of very small weaving machines – microbes [17]. Biotechnology can also make the construction sector more sustainable. For example, the UKRI-backed start-up company Mykor is developing carbon-negative construction materials from fungi waste [18].

Challenges and outlooks

It is indisputable that biotechnology-based innovations have offered a new dimension in the battle against the sustainability problem. However, it is important to acknowledge that embracing biotech for this purpose comes with its limitations. Biotech receives scrutiny from the likes of consumers, financial analysts, the media, and regulatory agencies. The way this can be solved is for biotech companies to leverage automated compliance software to keep up-to-date on legislative changes. A further challenge is contract manufacturing, with biotech companies looking to bring their products to market in this way. Although using contract manufacturers reduces capital and outlay costs, they do introduce uncertainties with quality assurance. A way this can be avoided is by companies using their own compliance management systems to increase downstream visibility. There is also the issue of competition in the biotech industry being intense, with companies having to keep up with the pace of new innovation to be able to survive long term. Maintaining this however is expensive and time-consuming for the respective companies with there being no guarantee that a new product will be successful. This serves to dissuade companies from pursuing more sustainable products especially when the trade-off is lower profitability and tighter margins. One way to overcome this uncertainty can be resolved by the company using quantitative risk management software or looking at change management software that incorporates quality measures [19].

In spite of these challenges, the adoption of biotechnology-based solutions to address sustainability has steadily increased in a range of industries, as was demonstrated above. Moreover, an increase in technological capabilities will enhance the ability of innovative companies to deliver more sustainable products, which will be less time-consuming and more cost-effective, ultimately leading to the growth of this field.

Nevertheless, the pace of technological development and rate of adoption of such products are highly dependent on the measures in place to support sustainability in various industries. These measures typically manifest as governmental policies and programmes that play a significant role in dictating where the field goes. It therefore begs the question, what steps have been taken, both internationally and nationally, to support the sustainability initiative, particularly in relation to biotechnology? This question, as well as, how biotechnology itself can become more sustainable, will be explored extensively in our next article.

As a closing statement, we must emphasise that the primary driver behind making our way of living more sustainable is environmental preservation, and ultimately, human preservation. We must therefore strive to find alternatives to harmful products and processes that have substantially contributed to the predicament we now face. Embracing innovative sectors such as biotechnology will undoubtedly enable us to achieve this critical goal.  

This incredibly important topic will be the focus of Innovation Forum Manchester’s next event, ‘biotech innovation for a sustainable future’, in early February. More details to be provided closer to the time.

References

  1. US EPA. (2016). Global Greenhouse Gas Emissions Data | US EPA. [online] Available at: https://www.epa.gov/ghgemissions/global-greenhouse-gas-emissions-data.
  2. Trentino Cultura. (2021). Permanent glaciers: the crisis of a habitat and its biodiversity that we can no longer ignore. [online] Available at: https://www.cultura.trentino.it/eng/Further-reading/Permanent-glaciers-the-crisis-of-a-habitat-and-its-biodiversity-that-we-can-no-longer-ignore
  3. EcoWatch (2021). Animal Agriculture Responsible for 57% of Greenhouse Gas Emissions From Food Production, Study Finds. [online] EcoWatch. Available at: https://www.ecowatch.com/animal-agriculture-greenhouse-gas-emissions-2655032993.html
  4. Martín-Lara, M.A., Godoy, V., Quesada, L., Lozano, E.J. and Calero, M. (2021). Environmental status of marine plastic pollution in Spain. Marine Pollution Bulletin, [online] 170, p.112677. doi:10.1016/j.marpolbul.2021.112677.
  5. The Coca-Cola Company. (2021). Bottles Made From 100% Plant Plastic | The Coca-Cola Company. [online] Available at: https://www.coca-colacompany.com/news/100-percent-plant-based-plastic-bottle
  6. Clara Rodríguez Fernández (2021). 10 Ways Biotechnology Makes the World More Sustainable. [online] Labiotech.eu. Available at: https://www.labiotech.eu/best-biotech/sustainable-biotechnology/
  7. Merriam-webster.com. (2022). Merriam-Webster Dictionary. [online] Available at: https://www.merriam-webster.com/dictionary/biotechnology.‌
  8. Chulalongkorn University (2022). Chula Launches a Bioproduct ‘Microbes to Clean Up Oil Spill in the Ocean’. [online] Prnewswire.co.uk. Available at: https://www.prnewswire.co.uk/news-releases/chula-launches-a-bioproduct-microbes-to-clean-up-oil-spill-in-the-ocean-301642450.html
  9. Mayer, J. (2021). The Golden Rice Project. [online] Goldenrice.org. Available at: https://www.goldenrice.org/index.php
  10. Vivergo Fuels. (2015). Process | Vivergo Fuels. [online] Available at: https://vivergofuels.com/process/
  11. The Supplant Company. (2022). The Supplant Company – Sugars from fiber. [online] Available at: https://supplant.com/
  12. Holmes, D., Humbird, D., Dutkiewicz, J., Tejeda-Saldana, Y., Duffy, B. and Datar, I. (2022). Cultured meat needs a race to mission not a race to market. Nature Food, [online] 3(10), pp.785–787. doi:10.1038/s43016-022-00586-9.
  13. Quest Meat. (2022). Quest Meat | The Food Revolution. [online] Available at: https://www.questmeat.com/
  14. Xampla. (2022). Xampla – natural alternative to plastic. [online] Available at: https://www.xampla.com/
  15. Niamh Leonard-Bedwell (2021). Gousto trials edible stock cube wrappers to cut plastic use. [online] The Grocer. Available at: https://www.thegrocer.co.uk/plastic/gousto-trials-edible-stock-cube-wrappers-to-cut-plastic-use/661116.article.
  16. Colorifix. (2019). Colorifix. [online] Available at: https://colorifix.com/ [Accessed 31 Oct. 2022].
  17. Modern Synthesis. (2022). Home – Modern Synthesis. [online] Available at: https://modern-synthesis.com/
  18. MYKOR (2022). MYKOR. [online] MYKOR. Available at: https://www.mykor.co.uk/
  19. ETQ. (2022). Top Challenges Facing Biotech Today and Tackling Them | ETQ. [online] Available at: https://www.etq.com/blog/top-3-challenges-facing-biotech-today-and-how-to-tackle-them/ .

Big Data and AI in Genomics in Focus: Event Recap

The rise of the digital era over the last half century has coincided with incredible breakthroughs in the field of genomics research. As we enter the 2020s, the convergence of these two worlds is coming to the fore.

On the 15th of March 2022, researchers, entrepreneurs, students, and genomics enthusiasts  had the opportunity to explore these exciting developments at Innovation Forum’s “Decoding the Human Genome Using Big Data and AI”. Over 40 attendees gathered at Manchester Science Park’s Bright Building, hosted by Bruntwood Scitech, and a further 35 people tuned in virtually to hear from industry experts and renowned academics both locally and nationally, about the challenges the field faces and the promise it holds in transforming healthcare.

 

AI and Big data in Genomics - Introduction

Our first speaker, Juhi Gupta, provided a breakdown of what “-omics research” represents, how the fields have evolved over the last few decades, and where they are heading. Juhi introduced the audience to the Christabel Pankhurst Institute. This Institute is an initiative led by the University of Manchester and the NHS that aims to support the translation of heath technology research and Innovation into healthcare practice. Here, Juhi leads the “Multi-omic Technologies for Healthcare” division. She was able to discuss the steps in the current pipeline that will facilitate the application of multi-omics technologies in the clinic. These steps are as follows:

  1. Scientists/Biologists/Researchers collect the multi-omics data (Big Data)
  2. Analysis of “multi-omics” data by Analysts/Statisticians/ data scientists
  3. Validation of findings (e.g. replication cohort)
  4. Translation of “multi-omics” findings into a technology that be applied in clinical practice

The current goal of this research unit is to bridge the gap between the first 3 steps and the last. Check out Juhi’s talk here.

AI and Big data in Genomics - Illumina Presentation

A current roadblock in achieving these objectives is an inability to decipher the sequencing data at the same pace as its generation. Our next speaker, Sam Hamlett from Illumina discussed the latest analysis tools offered by the company that promises to assist in overcoming this challenge.

Illumina is a prominent player in the genomics field and has played a big part in progressing it by reducing the cost of sequencing from $1 million to less than $1000. Sam explained the latest software analysis tool offered by Illumina, called DRAGEN. The DRAGEN platform provides comprehensive analysis of next generation sequencing data using machine learning and AI principles.

Finally, To round up the keynote speakers, Danuta Jeziorska from Nucleome Therapeutics described how her company has leveraged some of these breakthroughs in genomics technologies to investigate the dark genome.  Danuta talked about the opportunities that lie in exploring the non-coding genome, which holds more than 95% of disease-linked genetic variants, for drug discovery and development.

Nucleome Therapeutics is an example of real-world commercial application of genomics research and represents both the great strides that have been made in genomics, and the innovative drive that lies at the heart of this field.

AI and Big data in Genomics - Panellists

The next segment allowed the audience to engage with a panel of field experts. This includes academic experts (Simon Pearce and Cathine Felton from Cancer Research UK Manchester) and industry professionals (Agustin Guardiola and Markella Mikkelson from Apis Assay Technologies and MolMart diagnostic Genomics, respectively). The panel members shared insights into a host of thought-provoking genomics-based questions. This facilitated a rich discussion on the future of the field. Much of this discussion is available to view here.

The Innovation Forum is proud to have provided this platform to openly explore big data and AI in genomics. We would like to thank all participants, including the speakers, panellists, and the audience.

We would like to give special thanks  for Bruntood Scitech, who hosted the event in the fantastic Bright Building and aided in running the event.  

AI and Big data in Genomics - Audience

Are you interested in joining our future events? Would you like to showcase your business or become a member of our friendly team?

Get in touch through one of our various social media platforms:

                

From Hydrogels to Graphene: Innovation overcomes adversity

In a now familiar location, research enthusiasts and entrepreneurs gathered in Kro Bar on Oxford Road to participate in the latest edition of Pitch in a Pub, hosted by Innovation Forum Manchester, on the 28 October 2021.

The event marked the return of the team to in-person events, and the early buzz that built up in the main room was a reminder of what online events cannot reproduce. As the ever-present Manchester rain poured down on a dark Thursday evening, attendees were able to get comfortable in the vibrant pub environment, and with refreshments in hand and everyone seated, three fantastic speakers were able to delve into detail about their start-up stories.

First up was Dr Muhammad Umar, a Senior Scientist from AEH Innovative Hydrogel Ltd, a success story that the Innovation Forum knows all too well. AEH Innovative Hydrogel was founded by Dr Beenish Siddique, who was a participant in a previous edition of the Innovation Forum’s IMAGINE IF! pre-accelerator program and her venture has gone a long way since. Dr Umar described the company’s ambitions of utilizing their GelPonics hydrogel technology to help shape the future of agriculture and UK farming. The product facilitates improved sustainability of crop production, is recyclable and can be reused as a soil amendment to sequester carbon. AEH innovative hydrogel’s innovations have received substantial support in their quest to level up agriculture including funding support exceeding £1 million from the UK government. The start-up is also attempting to combine the GelPonics technology with a graphene-based IoT device for smart monitoring of crops in a collaboration with CHAP. As the world shifts its attention to battling global warming, companies fostering sustainability like AEH Innovative Hydrogel will play a pivotal role in overcoming this ongoing threat.

The audience were then able to hear from Dr Karen García Rodríguez, who co-founded Simplex Molecular, an early-stage start-up hoping to revolutionize molecular diagnostics. Karen’s story extends all the way to Mexico, where early conversations with her fellow co-founder, Maribel Montufar-Martinez, about the lack of convenient and rapid molecular diagnostics testing for point-of-care pathogen identification, inspired the two to start their venture. The company aims to develop and apply a portable cassette-based system that would detect pathogens more rapidly and at a higher sensitivity than the current gold-standard diagnostic tests. Karen was able to describe the challenges the pandemic posed for the young company, but also the successes that have helped them through this period, including the company’s Venture Further funding award by the University of Manchester.

Finally, we heard from Jason Laing, who founded Promake Ltd, a materials science company that specializes in the development of medical innovations. Jason’s entertaining pitching style and fascinating backstory certainly captivated the audience. Jason’s tragedy-turned-triumph personal story inspired him to utilize his 3D printing expertise to design and manufacture custom prosthetics and bone-replacement components. Since then, Jason has moved on to working with graphene, and his company received funding in two lots under the UK’s Public Health England National Microbiology Framework to develop graphene-based applications. Jason hopes his versatile tech can be applied in a variety of industries such as healthcare, med tech and diagnostics devices.

The event was supplemented with lengthy Q&As and followed by an active networking session. The level of engagement seen here was fantastic to observe and is the reason the team is excited to be back in person. This event was not possible without the contributions of all our speakers, and the Innovation Forum Manchester team is hugely thankful for their hard work.

The Innovation Forum is a global grassroots network of students, researchers, entrepreneurs, and professionals who aim to drive innovation in science and technology forwards by connecting academics, private companies and investors. We support our local innovation ecosystem by organising events, networking sessions and through our IMAGINE IF! Program; an accelerator and mentoring program for science ventures.

Are you interested in joining our future events? Would you like to showcase your business or become a member of our friendly team?

Get in touch through one of our various social media platforms:

Facebook: https://www.facebook.com/InnovationForumManchester/

Twitter: https://twitter.com/IFManchester

LinkedIn: https://www.linkedin.com/company/innovation-forum/

Instagram: https://www.instagram.com/innovation_forum_mcr/

Don’t miss our next event ‘Data science in genomics’ in Manchester in February 2022! We will be discussing current and future directions for Next-Gen Sequencing, AI in genomics, and personalized medicine. Stay updated on future announcements related to this event by following us on our social media channels.

Pitch in a Pub Manchester returns

Pitch in a Pub is an exciting series of events held by The Innovation Forum Manchester. The event is designed to bring together entrepreneurs, academics, professionals, researchers, and students to network and discuss all things life sciences, technology, and entrepreneurship. Our notable guest speakers present their business pitches and passion for innovation, followed by discussions and conversations with the audience in a relaxed environment.

This event is a perfect opportunity to hear from and engage with experienced entrepreneurs who have developed the know-how and built up the resilience needed to start a business in the life-sciences sector within the North West region. Gain insights into the stories that inspired these innovators and get invaluable tips on how you can follow their footsteps and start your own!

We are proud to say that the Pitch in a Pub event series has been a recurring success in building connections in the local start-up ecosystem and in facilitating engaging discussion between attending parties. We are therefore excited to announce that the latest edition of Pitch in a Pub will be held on the 28th of October at 6pm in KroBar, Manchester, Where we will be joined by speakers from local start-ups including AEH Innovative Hydrogel and Simplex Molecular. We look forward to welcoming you there!

 

The Innovation Forum is a global network of students, professionals, researchers, and entrepreneurs, seeking to drive innovative healthcare technology development by enabling connections between members of the community. Don’t miss out on our future events.

IMAGINE IF! in Innovation Forum Manchester

The Manchester IMAGINE IF! Programme is a local competition and pre-accelerator program tailored for health tech and life sciences early-stage ventures. The programme provides ample opportunity for scientific and tech innovators to propel their business to the next level through tailored mentorship, one-to-one workshops with professional service companies, and excellent networking opportunities across the Innovation Forum’s platform.

Successful applicants will be paired with a mentor, chosen from a pool of serial entrepreneurs and curated professionals to fit the applicant’s business needs, who will provide continual guidance and advice to develop their business idea and prepare for the IMAGINE IF! local finals.

The local finals will provide the pre-accelerator cohort with the chance to pitch to our curated audience, including leading North West angel and venture capital investors. The winner on the day will be determined by our experienced judges, including Claire Brown, investment director at BioCity, and Ian Sterritt, a senior innovation advisor at Innovate UK EEN. The local winner will be chosen 
based on the final business plans and live pitches, and will gain access to an afternoon of personalised 1:1 support with an experienced innovation advisor and venture builder, thanks to our sponsors Alderley Park Accelerator. The local finals event will also be sponsored by PhD Pigeon, a network organisation connecting PhD students to life sciences businesses, and Health Innovation Manchester, a public initiative promoting innovation in healthcare in the Greater Manchester region.

The IMAGINE IF! programme will culminate in the 2021 Global finals event in Barcelona, where winners from each local branch will pitch again following an intensive mentorship period. The prizes on offer for this event include a non-dilutive cash prize, free 6 month laboratory space and many more.

Do not miss the opportunity to bring your scientific vision to a commercial reality. Apply now at https://inno-forum.org/accelerator/.

We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.